Home Search

prostate cancer - search results

If you're not happy with the results, please do another search

Researchers Detail Clues to Prostate Cancer Therapy Resistance, ID New Treatment Strategy

This study revealed that antiandrogen therapy induces viral mimicry responses that are crucial for antitumor activity.
PSA positive

Genetic PSA Score May Improve Prostate Cancer Screening Accuracy

Incorporating genetic factors that influence prostate-specific antigen (PSA) level into prostate cancer screening may help reduce unnecessary invasive testing and improve the detection of aggressive disease.
A study from Karolinska Institutet in Sweden shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA. [Darryl Leja

Potential Approach for Prostate Cancer Treatment Uncovered

Researchers at CAS Center for Excellence in Molecular Cell Science of the Chinese Academy of Sciences demonstrated in mouse models the oncometabolite role of progesterone in advanced prostate cancer and strategies to eliminate its oncogenic effect.
Conceptual image for viral ethiology of prostate cancer

Prostate Cancer and Treatment Differs in Black Men

Black men with prostate cancer may respond well to androgen deprivation therapy (ADT)-based regimens, but they are less likely to receive such therapy than non-Blacks, according to a new multi-institutional retrospective analysis.
Illustration of the prostate organ in blue surrounded by red cancer cells to symbolize prostate cancer

Hormone-Sensitive Prostate Cancer Patients Survival Improved with Combination Therapy

A Phase III clinical trial led by scientists at Massachusetts General Hospital showed that adding darolutamide to androgen-deprivation therapy and chemotherapy extended the survival of men with metastatic, hormone-sensitive prostate cancer.
Loyal Golden Retriever Dog Sitting on a Green Backyard Lawn, Looks at Camera. Top Quality Dog Breed Pedigree Specimen Shows it's Smartness, Cuteness, and Noble Beauty. Colorful Portrait Shot

Prostate Cancer Similarities Between Man and Dog Helps ID New Drug Target

In a first-of-its-kind study on dogs with naturally occurring prostate cancer, scientists have discovered that blocking CCR4 expressing regulatory T cells that infiltrate tumors and prevent other immune cells from annihilating tumor cells, may be a promising therapeutic strategy for advanced prostate cancer in dogs and a subset of human patients.
Illustration showing tumor inside prostate gland and closeup view of prostate cancer cells to the left of the image.

Optimal High-Risk Prostate Cancer ADT Duration May Be Radiotherapy-Dependent

The analysis, which combined individual patient data from three different cohorts, showed that men receiving high-dose external beam radiotherapy (EBRT) alone may benefit from at least 18 months of ADT whereas those who receive EBRT plus a brachytherapy boost may be optimally managed with 18 months of ADT or less.
Image on screen of cancer screen. Artificial intelligence (AI) can be used in software that helps a pathologist interpret features of cancer in digitized images of samples.

Open Data Collaboration Shows AI Can Accurately Diagnose Prostate Cancer

A large study led by the Karolinska Institute in Sweden shows that artificial intelligence can be used to accurately diagnose and grade prostate cancer in a way that is generalizable across different populations.

23andMe Launches First Cancer Drug Trial and Gets FDA Nod for Prostate Cancer Marker

The launch of the clinical trial wholly sponsored by 23andMe is a pivotal achievement for the company’s therapeutic development division, which was started in 2015. But in 2020 GSK launched a trial of a drug candidate that came out of its collaboration with 23andMe, which started in 2018.
Patient going for Radiology - Cancer Treatment

Black Prostate Cancer Patients’ Radiation Therapy Outcomes Better Even with Higher Risk Disease

A meta-analysis of radiation therapy trials by UCLA Jonsson Comprehensive Cancer Center researchers showed that black men with more aggressive disease appeared to have better outcomes than their white counterparts.


Inside Precision Medicine